Start Genetic's Second Annual Genetic Testing Action Day
Start Genetic has officially announced the upcoming celebration of the second annual Genetic Testing Action Day, scheduled for July 25, 2026. This important date aims to boost global awareness regarding the significance of genetic testing in light of advancements in genetic medicine. This campaign is especially relevant for patients dealing with rare diseases, congenital anomalies, developmental disabilities, epilepsy, inherited cancers, and various other conditions.
The mission of this initiative is to enlighten individuals and families about how genetic testing can provide critical insights that can guide medical care, connect them to support resources, and facilitate their participation in ongoing research. Recent studies reveal a stark reality where a considerable number of patients do not have access to genetic testing, despite the rapidly evolving technology and its profound impact on prenatal and postnatal care.
For instance, an alarming analysis indicated that merely 16.9% of children diagnosed with autism have undergone genetic testing, even though longstanding recommendations advocate for such evaluations. The low figures underscore the barriers that prevent children and families from receiving potentially life-altering genetic evaluations.
Jenny Graham Beeson, co-founder of Start Genetic and a board member of CureSHANK, expressed her personal connection to the cause. With two children affected by different genetic disorders, Beeson recognizes how essential it is for families to receive timely information and potential treatment options tailored to genetic causes. "Genetic testing has the potential to shorten diagnostic odysseys that can last for years," Beeson emphasizes. "Families deserve access to information that can help explain a medical condition and identify personalized treatments."
Observed every year on July 25 in honor of Rosalind Franklin, whose groundbreaking work contributed to unraveling DNA's structure, Genetic Testing Action Day brings together individuals, families, healthcare professionals, researchers, and advocacy organizations to amplify the message of genetic testing and highlight its potential benefits. Participants are encouraged to engage in various activities on this special day to promote awareness, including:
- - Discussing with healthcare providers: Engaging in conversations about the appropriateness of genetic testing for their specific situations.
- - Sharing experiences: Utilizing social media platforms to narrate their genetic testing journeys, thereby fostering a community of support.
- - Educational resource dissemination: Accessing and distributing educational materials via StartGenetic.org, helping spread knowledge about genetic diagnostics.
- - Promoting the value of genetic diagnosis: Engaging in advocacy to raise awareness and understanding of genetic tests and their potential impact on healthcare.
Since its inception in 2025, Genetic Testing Action Day has rapidly evolved into a global awareness movement. This year, it enjoys support from industry partners, healthcare providers, and prominent patient advocacy organizations alike. Leading the initiative is Illumina, with contributions also coming from PYC Therapeutics, Neuren Pharmaceuticals, GRIN Therapeutics, Jaguar Gene Therapy, MyOme, and various anonymous donors.
Founded in 2025, Start Genetic is fundamentally a public awareness initiative aimed at enhancing the uptake and knowledge surrounding genetic testing. Notably, it operates under the larger umbrella of CureSHANK, a nonprofit organization dedicated to advancing therapies for Phelan-McDermid syndrome.
For anyone eager to join the movement this year, social media toolkits will be available for download starting June 23, 2026. Interested parties are encouraged to subscribe to the Start Genetic email list to receive ongoing updates, resources, and materials pertaining to Genetic Testing Action Day directly in their inboxes. Together, we can promote holistic care by empowering families with the information they need for genetic testing.